Participants will gain insight into the unique role of the HRSA 340B Prime Vendor, how Apexus serves in that role, and how the Prime Vendor Program (PVP) provides support and solutions to manufacturers, distributors, and covered entities (CE), including:
Wednesday, June 23
12:00–1:00 PM CDT
Adeola Chukwumah, PharmD, MPH, 340B ACE
Sourcing Director, Pharmacy
Adeola Chukwumah is Sourcing Director, Pharmacy for the 340B Prime Vendor Program (PVP), managed by Apexus. She manages brand strategy and coordinates the fulfillment of the organization’s supplier contract requirements with key pharmaceutical manufacturers. In this role, she also provides leadership in communicating the detailed advantages of the PVP with all pharmacy industry stakeholders. As a PharmD, she brings a combination of clinical, pharmacy account management, and marketing experience to Apexus. With her MPH, she has experience using public health tools and strategies to solve complex population issues.
Ms. Chukwumah has more than 18 years of pharmacy experience. Her experience includes clinical strategy roles with various large national plan sponsors. She was also a healthcare and pharmacy consultant at an international management firm. Her prior pharmacy experience also includes hospital and clinical community pharmacy practice.
Ms. Chukwumah earned her PharmD degree from Wayne State University, Detroit, Michigan, and her MPH degree from Johns Hopkins University, Baltimore, Maryland. She maintains pharmacy licenses in Michigan and Texas.
Ron Hartmann, PharmD
Vice President, Pharmacy Solutions
Ron Hartmann, PharmD, is currently Vice President, Pharmacy Solutions at Sagent Pharmaceuticals, supporting Sagent’s National Accounts, Business Development, Contracting, DSCSA, Senior Management and Sales teams. He also serves as Sagent’s primary 340B resource and provides support for Sagent’s 503B partner, SterRx.
Before joining Sagent in 2016, Mr. Hartmann spent nearly 16 years in the GPO industry, leading the pharmacy program at MedAssets. His clinical practice and management experience includes 10 years at the Washington Hospital Center in Washington, DC, followed by 7 years with the Sisters of Mercy Health System, St. Louis. While at Mercy, he served as director of pharmacy at what is now Mercy Hospital St. Louis and was corporate director of pharmacy for Unity Health.
Mr. Hartmann earned his bachelor’s degree in biology from the University of California, Irvine, and his PharmD from the University of Southern California. He completed a clinical pharmacy residency in general medicine through the Philadelphia College of Pharmacy and Science at the Hospital of the University of Pennsylvania.
Jason Mills, PharmD, MBA
Supply Chain System Administrator
Medical University of South Carolina
Jason Mills, PharmD, MBA, is the Supply Chain System Administrator for the Medical University of South Carolina (MUSC). Mr. Mills has held a variety of clinical pharmacy and supervisory roles since 2006, including serving as the Course Coordinator for Health System Management for the MUSC College of Pharmacy. His current role includes the oversight of hospital system pharmaceutical contracting, 340B program, controlled substances distribution/regulatory compliance, pharmacy inventory management, drug supply chain security act compliance, and repackaging.
Mr. Mills is president of the South Carolina Society of Health-System Pharmacists and will complete his term in March 2022.
He received his PharmD degree from the Ohio State University College of Pharmacy in 2006 and his MBA from the Citadel Graduate College in 2012.
Daniel Neal, MBA, 340B ACE
Director, 340B Product and Service Leader
Daniel Neal, MBA, is the 340B Product and Service Leader at Cardinal Health, where he has worked almost exclusively in the 340B space since 2008. In his current role, Mr. Neal acts as the head subject matter expert on 340B issues for the Cardinal Health enterprise, leading the development of strategy, policies, and service offerings across all business units (such as pharmaceutical, specialty, medical, nuclear, corporate) and classes of trade (for example, hospital, retail, state government, manufacturer). Mr. Neal also is responsible for managing Cardinal Health’s 340B consulting business, which offers expert guidance and project support to 340B covered entities.
Mr. Neal has a wide range of experience with 340B stakeholders, their diverse perspectives and priorities, and the different challenges they face with operationalizing and optimizing the program. He has spoken about 340B at several industry events, including the 340B University.
Mr. Neal received his MBA from The Ohio State University Fisher College of Business and is a 340B Apexus Certified Expert (ACE).
Ronald Sargent, MBA
National Accounts Director - GPOs
Ronald Sargent, MBA, is National Accounts Director, GPOs for GlaxoSmithKline (GSK), where he has worked for 29 years. Before assuming this role, he led contracting teams within GSK focused on the vaccines business. He has in-depth knowledge of the vaccines commercial landscape, including buy and bill, VFC, and public health models.
Mr. Sargent has more than 25 years of experience leading teams within the IDN, federal/DoD, public health, and hospital markets. His background has also included commercial roles within GSK and previously at Wyeth in vaccines, neurology, oncology, respiratory, and specialty pharmaceuticals.
Mr. Sargent holds a BS in economics from United States International University and an MBA from the University of San Diego.
The 340B PVP Manufacturer Refund Service (MRS) facilitates refunds to covered entities by refunding directly to affected facilities, primarily through its authorized distribution network.
The Prime Vendor supports the HRSA 340B Drug Pricing Program as a voluntary program for covered entities and manufacturers.
Learn essential manufacturer compliance elements of the 340B Program at no cost, 24/7. Module descriptions available here.
Find out more about what we do and how we can help you.